T welve years ago, a now infamous and retracted paper appeared in the L ancet 1 and launched a health scare. In it, researchers at the Royal Free medical school in London reported on 12 children with developmental disorders, and linked their problems to MMR (measles, mumps, and rubella) vaccination.
It was the proposed link between the vaccine and "regressive" autism that caught the headlines and sparked alarm. But the paper also claimed to have discovered a new gut pathology, reported in 11 of the 12 children, which the lead author, Andrew Wakefield, an academic gastroenterologist, would dub "autistic enterocolitis." "Researchers at the Royal Free Hospital School of Medicine may have discovered a new syndrome in children involving a new inflammatory bowel disease and autism," the institution announced in a press release in February 1998. 2 "Their paper . . . also suggests that in a number of cases the onset of behavioural symptoms was associated with MMR vaccination."
Six years later, the vaccine link was dropped when 10 of the paper's 13 authors retracted this claim 3 in the wake of my investigation for the Sunday Times. 4 And in February the entire paper was retracted, 5 after a General Medical Council panel decided that Wakefield was "dishonest" and "unethical." 6 Not a lot was said during the GMC hearing about "autistic enterocolitis," which Wakefield continues to insist is real. In 2005 he established a private clinic in Austin, Texas, focusing on researching and treating this "syndrome," And, although he resigned his post there after the GMC verdict, patients have been drawn from throughout America, and even the United Kingdom.
"We continually find inflammatory bowel disease that is different from Crohn's disease and ulcerative colitis," explains a doctor on the clinic's website. 7 "This was initially named 'autistic enterocolitis' by Dr Wakefield because of the unique pattern of inflammation." The Lancet, too, stood by this claim despite distancing itself from other aspects of the paper. "I do believe there was, and remains, validity to the connection between bowel disease and autism, which does need further investigation," the journal's editor, Richard Horton told the BBC in February 2004. 8 Dr Horton was speaking two days after I had presented him with the first findings of my now six year investigation for the Sunday Times that led to the GMC's charges. 4 Three weeks later came the paper's partial retraction.
Inflammatory evidence
So what survives of "autistic enterocolitis" after Wakefield's disgrace and the paper's retraction? The answer requires an understanding of Wakefield's mission, which was to discover precisely such a disease. Two years before the paper was published he was hired by a solicitor to help launch a speculative lawsuit against drug companies that manufactured MMR vaccine. And the instrument of their attack was to find what he called at the time "a new syndrome" 6 of bowel and brain disease caused by vaccines.
"In contrast to the IBD cases, which have a prima face [sic] gastrointestinal pathology, children with enteritis/disintegrative disorder form part of a new syndrome," said Wakefield and the lawyer in a confidential submission for legal aid funding for the project in June 1996, before any of the 12 children in the paper had been investigated. "Nonetheless, the evidence is undeniably in favour of a specific vaccine induced pathology." 9 But when the children were brought in to the Royal Free for ileocolonoscopy, between July 1996 and February 1997, a snag in W akefield's project emerged. The hospital's pathology service repeatedly judged colonic biopsy samples to be unexceptional, and thought bowel disease was a possibility in only one child.
In almost all cases, h i s t o p a t h o l o g i s t s reported a typical mix of cell types and numbers in the biopsy specimens. "Large bowel-type mucosa within normal histological limits," said, for example, the report for child 3 in the series. "No evidence of architectural distortion or increase in inflammatory cells in the lamina propria," said child 4's.
The lead pathologist for the Wakefield project, and an author of the now retracted paper, was Susan Davies, now at Addenbrooke's Hospital, Cambridge. At weekly meetings with paediatricians, the unexceptional results were confirmed. For four of the 12 she made additional notes recording the position more bluntly: "no abnormality detected." The biopsy slides are no longer available, according to one of the paper's authors, Pro fessor Amar Dhillon, but the GMC obtained all but one of the hospital pathology reports, and for the missing case I obtained the discharge summary. I passed the summary and reports to specialists for their reaction. They concluded that most of the 11 children reported as having non-specific colitis in the Lancet paper had been reported by the Royal Free as having normal pathology. "In the present reports and patients, overall, it is my impression that 8 of the 11 [for whom pathology reports were available] were normal," Karel Geboes, a professor in the gastrointestinal pathology unit of the Catholic University of Leuven, Belgium, told me. "Based on the reports it seems that [the remaining] three showed focal active colitis (of unclear significance). The significance of focal active colitis has been studied in adults and children by Greenson et al from Ann Arbor, and they showed that the risk for a chronic condition is low."
The Royal Free service did occasionally report inflammation-for example, in child 1. Although two colonic biopsy specimens were "within normal histological limits," one from this child's caecum showed neutrophils and cryptitis with "incipient crypt abscess formation." But Ingvar Bjarnason, of King's College London, a gastroenterologist with extensive paediatric experience, told me that such "caecal cryptitis" may be a normal phenomenon. "I would not call this colitis in the way gastroenterologists or histopathologists usually use the term."
That term, however, was repeatedly used in the Lancet paper. Eleven of the 12 children were said to have "non-specific colitis": a clinically significant inflammation of the large bowel. In all 11, it was said to be "chronic," while in four it was reported as both "acute and chronic."
With swollen glands in the terminal ileum (widely regarded as a benign 10 or normal 11 finding in children), this "colitis"-which was even cited in the retracted paper's title-was Wakefield's new disease. And yet the colitis was apparently invisible to the Royal Free's pathology service.
In fact the service identified findings suggestive of possible inflammatory bowel disease in only one of the 12 children. "The mild patchy generalised increase in inflammatory cells with lymphoid aggregates and follicles is not very specific but could be in keeping with low grade quiescent inflammatory bowel disease," it reported for child 2. But this inflammation resolved after two months' enteral feeding with a product now marketed as Modulen. A repeat ileocolonoscopy found no abnormality, and a food intolerance was diagnosed.
Mismatch
So how did the mismatches occur? On the one hand official pathology reports, which were presented to clinicians with the biopsy slides, showed almost nothing of importance in the colon. And on the other, a peer reviewed paper gave a headline finding of "non-specific colitis" in 11 of 12. The pathology reports were not a major focus for the GMC panel, but Wakefield and his co-accused, John Walker-Smith and Simon Murch, were occasionally asked about them.
"What I wondered about was whether or not it seemed strange that 11 children would have the same diagnosis," said Wendy Golding, a lay member of the panel, to Walker-Smith in August 2008. "They've come in with different issues, but they've got the same diagnosis." "That, of course, is the heart of the matter," replied the Royal Free's former professor of paediatric gastroenterology. "This is why we published in the Lancet, because there was this remarkable homogeneity between the findings. There was a remarkable similarity, as you are rightly saying."
"But you've changed what was actually diagnosed to what you wanted it to be." "I've certainly not changed it to what I wanted them to be, in any way," Walker-Smith hit back. "I mean there are changes, but I've suggested that these changes are not dramatic. It's just a way of looking at it. There were changes but not dramatic."
These changes-from normal to abnormal, or from healthy to diseased-had also raised concern in the mind of at least one of the paper's authors. In September 2007, Davies, the lead histopathologist for the Wakefield project, was examined at length before the panel. "When you were given a draft of the Lancet paper, did you read it?" she was asked by Sally Smith QC, for the doctors' regulator.
"Yes," Davies replied. "What was your overall view of the terminology used in relation to the histology findings in the Lancet paper, just when you read the paper?" "I was somewhat concerned with the use of the word colitis." "First of all, what did you understand that word to mean?" "I personally use that terminology, 'colitis,' when I see active inflammation, or a pattern of changes which suggest a specific diagnosis, and it was not my impression that the children coming through in the spasmodic way that they had, I [sic] had formulated some distinct pattern warranting that terminology."
Second look
Davies said her doubts about the draft paper were assuaged by three doctors in the medical school. Before publication, they had performed a "formalised review," re-examining the slides "in minute detail." That account has been corroborated by two other authors: Wakefield and Dhillon, now a p rofessor at the Royal Free and University C ollege Medical School. In statements over the years, both have said that this second look was blinded, and also controlled by healthy samples said to have been supplied by another London hospital.
"It was decided that the senior consultant histopathologist with expertise in intestinal disease (Dr Dhillon) should review all biopsies from autistic children, and that pathology should be graded on a pro forma (or grading sheet) designed by him," Wakefield said last March, in a now suspended complaint 12 to the UK Press Complaints Commission about one of my Sunday Times reports. 13 But no second look was pre-specified in the project's protocol.
14 It was mentioned in the paper. The paper's Patients and Methods section contains a 51 word paragraph describing the histology methods. "Formalin-fixed biopsy samples of ileum and colon were assessed and reported by a pathologist (SED)," this explains. "All tissues were assessed by three other clinical and experimental pathologists (APD, AA, AJW)." The initials refer to Susan Davies, Amar Dhillon, Andrew Anthony (then a junior, now a professor), and Andrew Wakefield. This apparent concurrence of four pathologists gave strength to the finding of a new bowel disease. But there is no suggestion in the paper that the second assessment caused findings to be substituted or changed, and since the paper's publication, Wakefield has insisted that it was merely a clinical case series, not research.
As for the histological grades produced in any second review the published paper includes nothing of these. In any case, specialists I've consulted say that grading sheets are research tools and don't generate clinical diagnoses such as colitis. Applying such terminology is a clinical decision: somebody must make a judgment. Moreover, in 1997, the British Society of Gastroenterology said that "inflammation requiring further investigation" to reach "a specific disease category" should be called "inflammationunclassified." 15 Not colitis. Would the Lancet have published on just "inflammation-unclassified"? Would any claim of a new syndrome have sounded credible? And how many peer reviewers would have felt comfortable approving the paper if they had known that the hospital pathology service reported biopsy specimens as largely normal, but they were then subjected to an unplanned second look and reinterpreted?
The response from one of the Lancet's peer reviewers of the Wakefield paper was "no": he wouldn't have felt comfortable. "I'm surprised the GMC didn't make more of this," said David Candy, paediatric gastroenterologist at St Richard's Ho spital, Chichester, who reviewed the paper in 1997. "That's an example of really naughty doing-to exclude the original pathology findings." And how bad was this "colitis," such that the hospital's pathology service didn't spot it as the children came through? Walker-Smith told the GMC panel that he had "concerns" about the service and its ability to detect inflammation. Yet inflammatory indices that were not reported in the Lancet paper, including serum C reactive protein concentrations and other blood tests, were almost all within normal ranges for the 12 children. 6 And as an alternative explanation for any inflammation that was present, nearly all of the children had constipation with megarectum 16 (unreported in the paper), which specialists say can cause cellular changes.
Through a senior member of the Royal Free medical school, I asked to speak to Dhillon. He declined, but gave a statement to the GMC: "I did not write the histology section of the paper and I cannot remember whether I made any amendments to the draft," explaining that his role was to grade biopsy inflammation with roman numerals on a grading sheet. "I do not know if any other histopathologists undertook the same review exercise with the slides as me, and I did not see their observations. "The person who wrote up the histological findings may have looked at the observations which I provided to Dr Wakefield. The person writing the research paper may have translated the roman numeral scores which I may have used into something readable."
Question of interpretation
So who translated these scores on the grading sheet into findings of "non-specific colitis" in the paper? Dhillon says it wasn't him. He says he would like to see the slides again, but they are missing from the Royal Free laboratory. "He [Dhillon] , Andrew Anthony, and Wakefield all looked at them," I was told, on Dhillon's behalf, by a senior member of staff at the Royal Free. "Andy [Wakefield] then synthesised their results into what appeared in the paper." Anthony, however, was a junior at the time, so couldn't have shouldered the responsibility. And Wakefield isn't a pathologist-he trained as a surgeon before joining the Royal Free as a researcher. So how the Roman numerical scores, histopathological gradings for a variety of sites in the colon, became the "colitis" findings might, under such circumstances, be anybody's guess.
However, in his complaint against me to the Press Complaints Commission, Wakefield last year offered a glimpse into how this happened. He gave a detailed explanation for child 8-the only girl in the Lancet series. This 3 year old's clinical notes said: "Histology normal." The pathology service reported three large bowel biopsy specimens: "All pieces of normal colonictype mucosa containing occasional lymphoid aggregates," a consultant reported. "Minimal Methods 12 children (mean age 6 years [range 3-10], 11 boys) were referred to a paediatric gastroenterology unit with a history of normal development followed by loss of acquired skills, including language, together with diarrhoea and abdominal pain. Children underwent gastroenterological, neurological, and developmental assessment and review of developmental records. Ileocolonoscopy and biopsy sampling, magnetic-resonance imaging (MRI), electroencephalography (EEG), and lumbar puncture were done under sedation. Barium follow-through radiography was done where possible. Biochemical, haematological, and immunological profiles were examined.
Findings Onset of behavioural symptoms was associated, by the parents, with measles, mumps, and rubella vaccination in eight of the 12 children, with measles infection in one child, and otitis media in another. All 12 children had intestinal abnormalities, ranging from lymphoid nodular hyperplasia to aphthoid ulceration. Histology showed patchy chronic inflammation in the colon in 11 children and reactive ileal lymphoid hyperplasia in seven, but no granulomas. Behavioural disorders included autism (nine), disintegrative psychosis (one), and possible postviral or vaccinal encephalitis (two). There were no focal neurological abnormalities and MRI and EEG tests were normal. Abnormal laboratory results were significantly raised urinary methylmalonic acid compared with agematched controls (p=0·003), low haemoglobin in four children, and a low serum IgA in four children.
Interpretation We identified associated gastrointestinal disease and developmental regression in a group of previously normal children, which was generally associated in time with possible environmental triggers.
Introduction
We saw several children who, after a period of apparent normality, lost acquired skills, including communication. They all had gastrointestinal symptoms, including abdominal pain, diarrhoea, and bloating and, in some cases, food intolerance. We describe the clinical findings, and gastrointestinal features of these children.
Patients and methods
12 children, consecutively referred to the department of paediatric gastroenterology with a history of a pervasive developmental disorder with loss of acquired skills and intestinal symptoms (diarrhoea, abdominal pain, bloating and food intolerance), were investigated. All children were admitted to the ward for 1 week, accompanied by their parents.
Clinical investigations
We took histories, including details of immunisations and exposure to infectious diseases, and assessed the children. In 11 cases the history was obtained by the senior clinician (JW-S). Neurological and psychiatric assessments were done by consultant staff (PH, MB) with HMS-4 criteria. Developmental histories included a review of prospective developmental records from parents, health visitors, and general practitioners. Four children did not undergo psychiatric assessment in hospital; all had been assessed professionally elsewhere, so these assessments were used as the basis for their behavioural diagnosis.
After bowel preparation, ileocolonoscopy was performed by SHM or MAT under sedation with midazolam and pethidine. Paired frozen and formalin-fixed mucosal biopsy samples were taken from the terminal ileum; ascending, transverse, descending, and sigmoid colons, and from the rectum. The procedure was recorded by video or still images, and were compared with images of the previous seven consecutive paediatric colonoscopies (four normal colonoscopies and three on children with ulcerative colitis), in which the physician reported normal appearances in the terminal ileum. Barium follow-through radiography was possible in some cases.
Also under sedation, cerebral magnetic-resonance imaging (MRI), electroencephalography (EEG) including visual, brain stem auditory, and sensory evoked potentials (where compliance made these possible), and lumbar puncture were done.
Laboratory investigations
Thyroid function, serum long-chain fatty acids, and cerebrospinal-fluid lactate were measured to exclude known causes of childhood neurodegenerative disease. Urinary methylmalonic acid was measured in random urine samples from eight of the 12 children and 14 age-matched and sex-matched normal controls, by a modification of a technique described previously.
Chromatograms were scanned digitally on computer, to analyse the methylmalonic-acid zones from cases and controls. Urinary methylmalonic-acid concentrations in patients and controls were compared by a two-sample t test. Urinary creatinine was estimated by routine spectrophotometric assay.
Children were screened for antiendomyseal antibodies and boys were screened for fragile-X if this had not been done before. Stool samples were cultured for Campylobacter spp, Salmonella spp, and Shigella spp and assessed by microscopy for ova and parasites. Sera were screened for antibodies to Yersinia enterocolitica.
Histology
Formalin-fixed biopsy samples of ileum and colon were assessed and reported by a pathologist (SED). Five ileocolonic biopsy series from age-matched and site-matched controls whose reports showed histologically normal mucosa were obtained for comparison. All tissues were assessed by three other clinical and experimental pathologists (APD, AA, AJW).
Ethical approval and consent
Investigations were approved by the Ethical Practices Committee of the Royal Free Hospital NHS Trust, and parents gave informed consent.
Results
Clinical details of the children are shown in tables 1 and 2. None had neurological abnormalities on clinical examination; MRI scans, EEGs, and cerebrospinal-fluid profiles were normal; and fragile X was negative. Prospective developmental records showed satisfactory achievement of early milestones in all children. The only girl (child number eight) was noted to be a slow developer compared with her older sister. She was subsequently found to have coarctation of the aorta. After surgical repair of the aorta at the age of 14 months, she progressed rapidly, and learnt to talk. Speech was lost later. Child four was kept under review for the first year of life because of wide bridging of the nose. He was discharged from follow-up as developmentally normal at age 1 year.
In eight children, the onset of behavioural problems had been linked, either by the parents or by the child's physician, with measles, mumps, and rubella vaccination. Five had had an early adverse reaction to immunisation (rash, fever, delirium; and, in three cases, convulsions). In these eight children the average interval from exposure to first behavioural symptoms was 6·3 days (range 1-14). Parents were less clear about the timing of onset of abdominal symptoms because children were not toilet trained at the time or because behavioural features made children unable to communicate symptoms.
One child (child four) had received monovalent measles vaccine at 15 months, after which his development slowed (confirmed by professional assessors). No association was made with the vaccine at this time. He received a dose of measles, mumps, and rubella vaccine at age 4·5 years, the day after which his mother described a striking deterioration in his behaviour that she did link with the immunisation. Child nine received measles, mumps, and rubella vaccine at 16 months. At 18 months he developed recurrent antibioticresistant otitis media and the first behavioural symptoms, including disinterest in his sibling and lack of play. Table 2 summarises the neuropsychiatric diagnoses; the apparent precipitating events; onset of behavioural features; and age of onset of both behaviour and bowel symptoms.
Laboratory tests
All children were antiendomyseal-antibody negative and common enteric pathogens were not identified by culture, microscopy, or serology. Urinary methylmalonic-acid excretion was significantly raised in all eight children who R E T R 
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Endoscopic findings
The caecum was seen in all cases, and the ileum in all but two cases. Endoscopic findings are shown in table 1. Macroscopic colonic appearances were reported as normal in four children. The remaining eight had colonic and rectal mucosal abnormalities including granularity, loss of vascular pattern, patchy erythema, lymphoid nodular hyperplasia, and in two cases, aphthoid ulceration. Four cases showed the "red halo" sign around swollen caecal lymphoid follicles, an early endoscopic feature of Crohn's disease. The most striking and consistent feature was lymphoid nodular hyperplasia of the terminal ileum which was seen in nine children (figure 2), and identified by barium follow-through in one other child in whom the ileum was not reached at endoscopy. The normal endoscopic appearance of the terminal ileum (figure 2) was seen in the seven children whose images were available for comparison.
Histological findings
Histological findings are summarised in table 1.
Terminal ileum A reactive lymphoid follicular hyperplasia was present in the ileal biopsies of seven children. In each case, more than three expanded and confluent lymphoid follicles with reactive germinal centres were identified within the tissue section ( figure 3 ). There was no neutrophil infiltrate and granulomas were not present.
Colon The lamina propria was infiltrated by mononuclear cells (mainly lymphocytes and macrophages) in the colonic-biopsy samples. The extent ranged in severity from scattered focal collections of cells beneath the surface epithelium (five cases) to diffuse infiltration of the mucosa (six cases). There was no increase in intraepithelial lymphocytes, except in one case, in which numerous lymphocytes had infiltrated the surface epithelium in the proximal colonic biopsies. Lymphoid follicles in the vicinity of mononuclear-cell infiltrates showed enlarged germinal centres with reactive changes that included an excess of tingible body macrophages.
There was no clear correlation between the endoscopic appearances and the histological findings; chronic inflammatory changes were apparent histologically in endoscopically normal areas of the colon. In five cases there was focal acute inflammation with infiltration of the lamina propria by neutrophils; in three of these, neutrophils infiltrated the caecal ( figure 3 ) and rectalcrypt epithelium. There were no crypt abscesses. Occasional bifid crypts were noted but overall crypt architecture was normal. There was no goblet-cell depletion but occasional collections of eosinophils were seen in the mucosa. There were no granulomata. Parasites and organisms were not seen. None of the changes described above were seen in any of the normal biopsy specimens.
Discussion
We describe a pattern of colitis and ileal-lymphoidnodular hyperplasia in children with developmental disorders. Intestinal and behavioural pathologies may have occurred together by chance, reflecting a selection bias in a self-referred group; however, the uniformity of the intestinal pathological changes and the fact that previous studies have found intestinal dysfunction in children with autistic-spectrum disorders, suggests that the connection is real and reflects a unique disease process.
Asperger first recorded the link between coeliac disease and behavioural psychoses.
Walker-Smith and colleagues detected low concentrations of alpha-1 antitrypsin in children with typical autism, and D'Eufemia and colleagues identified abnormal intestinal permeability, a feature of small intestinal enteropathy, in 43% of a group of autistic children with no gastrointestinal symptoms, but not in matched controls. These studies, together with our own, including evidence of anaemia and IgA deficiency in some children, would support the hypothesis that the consequences of an inflamed or dysfunctional intestine may play a part in behavioural changes in some children. A=child three; lymphoid hyperplasia with extensive, confluent lymphoid nodules. B=child three; dense infiltration of the lamina propria crypt epithelium by neutrophils and mononuclear cells. Stained with haematoxylin and eosin.
The "opioid excess" theory of autism, put forward first by Panksepp and colleagues and later by Reichelt and colleagues and Shattock and colleagues proposes that autistic disorders result from the incomplete breakdown and excessive absorption of gut-derived peptides from foods, including barley, rye, oats, and caesin from milk and dairy produce. These peptides may exert centralopioid effects, directly or through the formation of ligands with peptidase enzymes required for breakdown of endogenous central-nervous-system opioids, leading to disruption of normal neuroregulation and brain development by endogenous encephalins and endorphins.
One aspect of impaired intestinal function that could permit increased permeability to exogenous peptides is deficiency of the phenyl-sulphur-transferase systems, as described by Waring.
The normally sulphated glycoprotein matrix of the gut wall acts to regulate cell and molecular trafficking. Disruption of this matrix and increased intestinal permeability, both features of inflammatory bowel disease, may cause both intestinal and neuropsychiatric dysfunction. Impaired enterohepatic sulphation and consequent detoxification of compounds such as the phenolic amines (dopamine, tyramine, and serotonin) may also contribute. Both the presence of intestinal inflammation and absence of detectable neurological abnormality in our children are consistent with an exogenous influence upon cerebral function. Lucarelli's observation that after removal of a provocative enteric antigen children achieved symptomatic behavioural improvement, suggests a reversible element in this condition.
Despite consistent gastrointestinal findings, behavioural changes in these children were more heterogeneous. In some cases the onset and course of behavioural regression was precipitous, with children losing all communication skills over a few weeks to months. This regression is consistent with a disintegrative psychosis (Heller's disease), which typically occurs when normally developing children show striking behaviour changes and developmental regression, commonly in association with some loss of coordination and bowel or bladder function. Disintegrative psychosis is typically described as occurring in children after at least 2-3 years of apparently normal development.
Disintegrative psychosis is recognised as a sequel to measles encephalitis, although in most cases no cause is ever identified. Viral encephalitis can give rise to autistic disorders, particularly when it occurs early in life. Rubella virus is associated with autism and the combined measles, mumps, and rubella vaccine (rather than monovalent measles vaccine) has also been implicated. Fudenberg noted that for 15 of 20 autistic children, the first symptoms developed within a week of vaccination. Gupta commented on the striking association between measles, mumps, and rubella vaccination and the onset of behavioural symptoms in all the children that he had investigated for regressive autism. We did not prove an association between measles, mumps, and rubella vaccine and the syndrome described. Virological studies are underway that may help to resolve this issue.
If there is a causal link between measles, mumps, and rubella vaccine and this syndrome, a rising incidence might be anticipated after the introduction of this vaccine in the UK in 1988. Published evidence is inadequate to show whether there is a change in incidence or a link with measles, mumps, and rubella vaccine. A genetic predisposition to autistic-spectrum disorders is suggested by over-representation in boys and a greater concordance rate in monozygotic than in dizygotic twins. In the context of susceptibility to infection, a genetic association with autism, linked to a null allele of the complement (C) 4B gene located in the class III region of the majorhistocompatibility complex, has been recorded by Warren and colleagues. C4B-gene products are crucial for the activation of the complement pathway and protection against infection: individuals inheriting one or two C4B null alleles may not handle certain viruses appropriately, possibly including attenuated strains.
Urinary methylmalonic-acid concentrations were raised in most of the children, a finding indicative of a functional vitamin B12 deficiency. Although vitamin B12 concentrations were normal, serum B12 is not a good measure of functional B12 status. Urinary methylmalonic-acid excretion is increased in disorders such as Crohn's disease, in which cobalamin excreted in bile is not reabsorbed. A similar problem may have occurred in the children in our study. Vitamin B12 is essential for myelinogenesis in the developing central nervous system, a process that is not complete until around the age of 10 years. B12 deficiency may, therefore, be a contributory factor in the developmental regression.
We have identified a chronic enterocolitis in children that may be related to neuropsychiatric dysfunction. In most cases, onset of symptoms was after measles, mumps, and rubella immunisation. Further investigations are needed to examine this syndrome and its possible relation to this vaccine.
Addendum:
Up to Jan 28, a further 40 patients have been assessed; 39 with the syndrome. inflammatory changes. May be result of operative artefact." Wakefield wrote: "When the biopsies were reviewed and scored by experts in bowel pathology-namely, Drs Dhillon and Anthony-these doctors determined that there was mild inflammation in the caecum, ascending colon, and rectum," he said. "This was correctly reported as non-specific colitis in the Lancet." In other words, it looks like it was Wakefield who translated the scores.
Contributors
Pathology textbooks and journal reviews, however, make it clear that this interpretation was unorthodox to say the least. [17] [18] [19] Minimal or mild inflammatory changes, of themselves, shouldn't be reported as colitis. Johns Hopkins pathologist Elizabeth Montgomery explains the point in her 2005 textbook. "The diagnosis of colitis requires evidence of injury to the epithelium, and not simply a mild increase in the amount of inflammatory cells within the lamina propria." 20 No such injury (apart from a bit of architectural distortion) was reported for nearly all of the children.
So is autistic enterocolitis just a normal finding in biopsy specimens from autistic children? Wakefield says "no": the disease is real. But recent analyses of faecal calprotectin (a marker for possible inflammatory bowel disease) and stool patterns in autistic children have failed to find any distinctive inflammation. 21 22 And an expert literature review, while stressing a need for better gastrointestinal services, hasn't identified anything special in autistic patients. 23 Meanwhile, the disease born of a deal with a solicitor was last year hammered in a lawsuit. Throwing out a claim for vaccine damage from a patient at Wakefield's Texas clinic, a US judge said that not only has the "autistic enterocolitis theory not been accepted into gastroenterology textbooks, but that theory, and Dr Wakefield's role in its development, have been strongly criticised as constituting defective or fraudulent s cience." 24 So what should we make of all this? Now the Lancet paper is retracted, its findings don't officially exist. And, if Dhillon is right in saying the slides can't be found, the ultimate proof is missing. All we have are the pathology reports, which independent specialists seem to agree are largely unremarkable. "They wanted this bad," commented Tom MacDonald, dean of research at Barts and the London School of Medicine and coauthor of Immunology and Diseases of the Gut. 25 "If I was the referee and the routine pathologists reported that 8/11 were within normal limits, or had trivial changes, but this was then revised by other people to 11/12 having non-specific colitis, then I would just tell the editor to reject the paper." Col to come mmR vaccination tnolan thinks that compulsory vaccination is "not a bad idea-but would middle class vaccine suspicious folk put up with it?" Daxx disagrees: "No. This is yet another example of the increasingly paternalistic attitude taken by the medical profession towards the general community."
audreyb reminds us what happens elsewhere in the world: "It's amazing how fast parents who have previously refused the vaccine bring their children to be immunised when they find that their children won't be able to go into school in their new Australian or US home if they haven't been vaccinated. Then we get demands for an immediate nurse appointment as they are flying out the next day." Neil G is clear that "Parents who want to send their kids to publicly funded schools ought also to have to abide by public policies in respect of health."
A doc2doc poll asked, "should children be denied access to school if they haven't had the MMR vaccine?" some participants left comments (http://tiny.cc/7318v).
A related discussion on doc2doc deals with the Lancet's retraction of Wakefield's MMR paper (http://tiny.cc/1su6c).
HelenJ says: "Talk about closing the stable door after the horse has bolted. Given how thoroughly Andrew Wakefield has been dressed down by the General Medical Council, there's no way the Lancet could stand by the paper. On the other hand, there is an argument for the Lancet not having retracted the paper earlier: the article was a case study of 12 children and on the surface isn't particularly dodgy." Andrew Morrice thinks that: "Wakefield was caught because he made a great deal of his findings and attacked the UK vaccination programme, which is staunchly defended by most doctors. How much more dodgy nonsense is there gently swilling about in our literature, quoted and built on as fact? If it takes 12 years and one of the most spectacular GMC cases ever to get a paper retracted, I'd say an awful lot."
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